Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

Subjects:

Funnel plots of studies included in the meta-analysis assessing by Solima Sabeel (9545738)

Subjects:

Summary of non-randomized studies. by Solima Sabeel (9545738)

Subjects:

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

Subjects:

Newcastle-Ottawa scale. by Solima Sabeel (9545738)

Subjects:

Correlations between significantly different microbiota and metabolites. by Bhuripit Saraphol (20855573)

Subjects:

(A-C) Force versus drill depth and torque versus drill depth. by Marsel Ganeyev (21453399)

Subjects:

Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

Subjects:

Data supporting this article. by Karel Joineau (21799908)

Subjects:

CONSORT diagram showing the flow of participants through each stage of the DOREPAR randomized trial for the main outcome (change of VAS). by Karel Joineau (21799908)

Subjects:

Demographic and clinical data at baseline. by Karel Joineau (21799908)

Subjects:

Changes in clinical variables. by Karel Joineau (21799908)

Subjects:

Change of functional connectivity in the SMN after intervention. by Karel Joineau (21799908)

Subjects:

Connectivity between the left nucleus accumbens and two clusters. by Karel Joineau (21799908)

Subjects:

Design of the protocol. by Karel Joineau (21799908)

Subjects:

Schema of the reflexology circuit and the stimulated reflex zones. a. by Karel Joineau (21799908)

Subjects:

The strength of the commute time-functional connectivity relationship demonstrates weak pathological significance and weak dependency on age. by Rostam M. Razban (22232522)

“…The corresponding Kolmogorov-Smirnov pairwise tests are not significant (S5 Table in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0331085#pone.0331085.s001" target="_blank">SI</a>). …”

Viability of <i>L</i>. <i>intracellularis</i>. by Huan W. Yang (19746645)

Subjects:

(A-B): Mean intraocular pressure (IOP) (A) and mean number of glaucoma medications (B) with standard deviations are shown for XEN (grey) and PRESERFLO (black) groups at baseline (p... by Cemre Altas (22537656)